Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?
- García Trevijano Cabetas, M.
- Escario-Gómez, M.
- González-Del Valle, L.
- Sobrino Jiménez, C.
- Bilbao Gomez-Martino, C.
- Romero-Garrido, J.A.
- Benedi-González, J.
- Espinosa Arranz, E.
- Díaz Almirón, M.
- Herrero Ambrosio, A.
ISSN: 2047-9964, 2047-9956
Datum der Publikation: 2021
Ausgabe: 30
Nummer: 5
Seiten: 268-272
Art: Artikel